Browsing byAuthorBartley, N

Jump to a point in the index:
Showing results 1 to 20 of 28  next >
Issue DateTitleAuthor(s)
2023-09Family communication and results disclosure after germline sequencing: A mixed methods study.Harrison, C; Bartley, N; Jacobs, C; Best, M; Vatter, S; Meiser, B; Ballinger, ML; Thomas, DM; Butow, P; members of the PiGeOn Project,
2023-06Vaccine hesitancy in cancer patients: A rapid review.Butow, P; Shaw, J; Bartley, N; Milch, V; Sathiaraj, R; Turnbull, S; Der Vartanian, C
2022-10Validation of the Knowledge of Genome Sequencing (KOGS) scale in cancer patients.Butow, P; Napier, C; Campbell, R; Bartley, N; Best, M; Ballinger, ML
2022-10Return of comprehensive tumour genomic profiling results to advanced cancer patients: a qualitative study.Best, MC; Bartley, N; Napier, CE; Fisher, A; Ballinger, ML; Thomas, DM; Goldstein, D; Tucker, K; Biesecker, BB; Butow, P
2022-08Preferences for return of germline genome sequencing results for cancer patients and their genetic relatives in a research setting.Best, MC; Butow, P; Savard, J; Jacobs, C; Bartley, N; Davies, G; Napier, CE; Ballinger, ML; Thomas, DM; Biesecker, B; Tucker, KM; Juraskova, I; Meiser, B; Schlub, T; Newson, AJ
2022-07-18Experiences and perspectives of cancer stakeholders regarding COVID-19 vaccination.Bartley, N; Havard, P; Butow, P; Shaw, J; COVID-19 Cancer Stakeholder Authorship Group,
2022-07Validation of the multidimensional impact of Cancer Risk Assessment Questionnaire to assess impact of waiting for genome sequencing results.Best, M; Napier, C; Schlub, T; Bartley, N; Biesecker, B; Ballinger, M; Butow, P
2022-07Psychological impact of comprehensive tumor genomic profiling results for advanced cancer patients.Butow, PN; Best, MC; Davies, G; Schlub, T; Napier, CE; Bartley, N; Ballinger, ML; Juraskova, I; Meiser, B; Goldstein, D; Biesecker, B; Thomas, DM; members of the PiGeOn Project,
2022-06Psychological predictors of cancer patients' and their relatives' attitudes towards the return of genomic sequencing results.Meiser, B; Butow, P; Davies, G; Napier, CE; Schlub, TE; Bartley, N; Juraskova, I; Ballinger, ML; Thomas, DM; Best, MC; members of the Psychosocial Issues in Genomics in Oncology (PiGeOn) Project,; Jacobs, C
2022-06Psychological outcomes in advanced cancer patients after receiving genomic tumor profiling results.Vatter, S; Schlub, TE; Napier, CE; Best, MC; Bartley, N; Juraskova, I; Meiser, B; Ballinger, ML; Biesecker, BB; Goldstein, D; Thomas, DM; Butow, P; Members of the PiGeOn Project,
2022-03Cancer patient knowledge about and behavioral intentions after germline genome sequencing.Napier, CE; Davies, G; Butow, PN; Schlub, TE; Best, MC; Bartley, N; Juraskova, I; Meiser, B; Tucker, KM; Biesecker, BB; Thomas, DM; Ballinger, ML; Members of the PiGeOn Project,
2022-02Value of whole-genome sequencing to Australian cancer patients and their first-degree relatives participating in a genomic sequencing study.Butow, P; Davies, G; Napier, CE; Bartley, N; Ballinger, ML; Biesecker, B; Juraskova, I; Meiser, B; Schlub, T; Thomas, DM; Goldstein, D; Best, MC; Members of the PiGeOn Project,
2022-02Effectively communicating comprehensive tumor genomic profiling results: Mitigating uncertainty for advanced cancer patients.Bartley, N; Best, MC; Biesecker, BB; Fisher, A; Goldstein, D; Meiser, B; Thomas, DM; Ballinger, ML; Butow, P
2021-11-10Psychological predictors of advanced cancer patients' preferences for return of results from comprehensive tumor genomic profiling.Meiser, B; Butow, P; Davies, G; Napier, CE; Schlub, TE; Bartley, N; Juraskova, I; Ballinger, ML; Thomas, DM; Tucker, K; Goldstein, D; Biesecker, BB; Best, MC; Members of the Psychosocial Issues in Genomics in Oncology (PiGeOn) Project,
2021-11Longitudinal patterns in fear of cancer progression in patients with rare, advanced cancers undergoing comprehensive tumour genomic profiling.Butow, P; Müller, F; Napier, CE; Bartley, N; Ballinger, ML; Biesecker, B; Juraskova, I; Meiser, B; Schlub, TE; Thomas, DM; Goldstein, D; Best, MC; Members of the PiGeOn Project,
2021-08Pursuing germline genome sequencing to reduce illness uncertainty may involve additional uncertainties for cancer patients: A mixed-methods study.Bartley, N; Best, M; Butow, P
2021-07-26Does undertaking genome sequencing prompt actual and planned lifestyle-related behavior change in cancer patients and survivors? A qualitative studyVatter, S; Bartley, N; Best, M; Juraskova, I; Jacobs, C; Ballinger, ML; Thomas, DM; Butow, P
2021-06Motivations and barriers to pursue cancer genomic testing: A systematic review.Smith-Uffen, M; Bartley, N; Davies, G; Best, M
2021Family communication about genomic sequencing: A qualitative study with cancer patients and relatives.Smit, AK; Bartley, N; Best, MC; Napier, CE; Butow, P; Newson, AJ; Tucker, K; Ballinger, ML; Thomas, DM; Jacobs, C; Meiser, B; Goldstein, D; Savard, J; Juraskova, I; PiGeOn authorship group,
2021Cancer Patient Experience of Uncertainty While Waiting for Genome Sequencing Results.Bartley, N; Napier, CE; Butt, Z; Schlub, TE; Best, MC; Biesecker, BB; Ballinger, ML; Butow, P